139 related articles for article (PubMed ID: 11197350)
1. Design and synthesis of a multivalent homing device for targeting to murine CD22.
Sliedregt LA; van Rossenberg SM; Autar R; Valentijn AR; van der Marel GA; van Boom JH; Piperi C; van der Merwe PA; Kuiper J; van Berkel TJ; Biessen EA
Bioorg Med Chem; 2001 Jan; 9(1):85-97. PubMed ID: 11197350
[TBL] [Abstract][Full Text] [Related]
2. A structure-function study of ligand recognition by CD22beta.
van Rossenberg SM; Sliedregt LA; Autar R; Piperi C; Van Der Merwe AP; van Berkel TJ; Kuiper J; Biessen EA
J Biol Chem; 2001 Apr; 276(16):12967-73. PubMed ID: 11152460
[TBL] [Abstract][Full Text] [Related]
3. Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand.
Engel P; Wagner N; Miller AS; Tedder TF
J Exp Med; 1995 Apr; 181(4):1581-6. PubMed ID: 7535343
[TBL] [Abstract][Full Text] [Related]
4. Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily.
Kelm S; Pelz A; Schauer R; Filbin MT; Tang S; de Bellard ME; Schnaar RL; Mahoney JA; Hartnell A; Bradfield P
Curr Biol; 1994 Nov; 4(11):965-72. PubMed ID: 7533044
[TBL] [Abstract][Full Text] [Related]
5. Natural ligands of the B cell adhesion molecule CD22 beta carry N-linked oligosaccharides with alpha-2,6-linked sialic acids that are required for recognition.
Powell LD; Sgroi D; Sjoberg ER; Stamenkovic I; Varki A
J Biol Chem; 1993 Apr; 268(10):7019-27. PubMed ID: 8463235
[TBL] [Abstract][Full Text] [Related]
6. A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33.
Sgroi D; Nocks A; Stamenkovic I
J Biol Chem; 1996 Aug; 271(31):18803-9. PubMed ID: 8702538
[TBL] [Abstract][Full Text] [Related]
7. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.
Tedder TF; Tuscano J; Sato S; Kehrl JH
Annu Rev Immunol; 1997; 15():481-504. PubMed ID: 9143697
[TBL] [Abstract][Full Text] [Related]
8. The amino-terminal immunoglobulin-like domain of sialoadhesin contains the sialic acid binding site. Comparison with CD22.
Nath D; van der Merwe PA; Kelm S; Bradfield P; Crocker PR
J Biol Chem; 1995 Nov; 270(44):26184-91. PubMed ID: 7592823
[TBL] [Abstract][Full Text] [Related]
9. The oligosaccharide binding specificities of CD22 beta, a sialic acid-specific lectin of B cells.
Powell LD; Varki A
J Biol Chem; 1994 Apr; 269(14):10628-36. PubMed ID: 8144652
[TBL] [Abstract][Full Text] [Related]
10. The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes.
Engel P; Nojima Y; Rothstein D; Zhou LJ; Wilson GL; Kehrl JH; Tedder TF
J Immunol; 1993 Jun; 150(11):4719-32. PubMed ID: 7684411
[TBL] [Abstract][Full Text] [Related]
11. Characterization of sialyloligosaccharide binding by recombinant soluble and native cell-associated CD22. Evidence for a minimal structural recognition motif and the potential importance of multisite binding.
Powell LD; Jain RK; Matta KL; Sabesan S; Varki A
J Biol Chem; 1995 Mar; 270(13):7523-32. PubMed ID: 7706299
[TBL] [Abstract][Full Text] [Related]
12. Constitutively unmasked CD22 on B cells of ST6Gal I knockout mice: novel sialoside probe for murine CD22.
Collins BE; Blixt O; Bovin NV; Danzer CP; Chui D; Marth JD; Nitschke L; Paulson JC
Glycobiology; 2002 Sep; 12(9):563-71. PubMed ID: 12213789
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of a multivalent display of a CD22-binding trisaccharide.
Yang ZQ; Puffer EB; Pontrello JK; Kiessling LL
Carbohydr Res; 2002 Oct; 337(18):1605-13. PubMed ID: 12423961
[TBL] [Abstract][Full Text] [Related]
14. Binding of human plasma sialoglycoproteins by the B cell-specific lectin CD22. Selective recognition of immunoglobulin M and haptoglobin.
Hanasaki K; Powell LD; Varki A
J Biol Chem; 1995 Mar; 270(13):7543-50. PubMed ID: 7706301
[TBL] [Abstract][Full Text] [Related]
15. Localization of the putative sialic acid-binding site on the immunoglobulin superfamily cell-surface molecule CD22.
van der Merwe PA; Crocker PR; Vinson M; Barclay AN; Schauer R; Kelm S
J Biol Chem; 1996 Apr; 271(16):9273-80. PubMed ID: 8621588
[TBL] [Abstract][Full Text] [Related]
16. The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound.
Kelm S; Gerlach J; Brossmer R; Danzer CP; Nitschke L
J Exp Med; 2002 May; 195(9):1207-13. PubMed ID: 11994426
[TBL] [Abstract][Full Text] [Related]
17. Natural ligands of the B cell adhesion molecule CD22 beta can be masked by 9-O-acetylation of sialic acids.
Sjoberg ER; Powell LD; Klein A; Varki A
J Cell Biol; 1994 Jul; 126(2):549-62. PubMed ID: 8034751
[TBL] [Abstract][Full Text] [Related]
18. Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells.
Law CL; Aruffo A; Chandran KA; Doty RT; Clark EA
J Immunol; 1995 Oct; 155(7):3368-76. PubMed ID: 7561031
[TBL] [Abstract][Full Text] [Related]
19. Difference in CD22 molecules in human B cells and basophils.
Toba K; Hanawa H; Fuse I; Sakaue M; Watanabe K; Uesugi Y; Higuchi W; Takahashi M; Aizawa Y
Exp Hematol; 2002 Mar; 30(3):205-11. PubMed ID: 11882357
[TBL] [Abstract][Full Text] [Related]
20. CD22 antigen: biosynthesis, glycosylation and surface expression of a B lymphocyte protein involved in B cell activation and adhesion.
Schwartz-Albiez R; Dörken B; Monner DA; Moldenhauer G
Int Immunol; 1991 Jul; 3(7):623-33. PubMed ID: 1716973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]